Form 4: Astrana Health's Chief Medical Officer, Dinesh Kumar, Reports Stock Transactions

Dinesh Kumar, Chief Medical Officer of Astrana Health, reports acquisition of restricted stock units and disposition of shares to cover tax obligations.

Summary

• On March 5, 2025, Dinesh Kumar, the Chief Medical Officer of Astrana Health, Inc., reported transactions involving the company's stock.
• Kumar acquired 26,701 shares of common stock in the form of restricted stock units.
• These restricted stock units will vest in eight equal semi-annual installments starting September 5, 2025, contingent upon continued employment with the Issuer.
• Kumar also disposed of 7,866 shares of common stock at a price of $27.19 to cover tax withholding obligations related to the vesting of restricted stock.
• Following these transactions, Kumar beneficially owns 228,126 shares of Astrana Health, Inc.
• This total includes shares of restricted stock and restricted stock units that will vest over time, subject to continued employment and the achievement of certain performance goals.
• It also includes 629 shares acquired under the Issuer's Employee Stock Purchase Plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing showing standard compensation practices. The acquisition of stock units is a positive sign, but the sale for tax obligations is a neutral event.

Positives

• The grant of restricted stock units to the Chief Medical Officer aligns his interests with the long-term performance of the company.
• Participation in the Employee Stock Purchase Plan indicates confidence in the company's future.

Negatives

• The disposition of shares to cover tax obligations, while common, slightly reduces the officer's direct equity stake.

Risks

• The vesting of restricted stock and restricted stock units is contingent upon continued employment and, in some cases, the achievement of performance goals, creating potential risk if these conditions are not met.
• Fluctuations in the stock price could impact the value of the holdings.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedules for restricted stock and restricted stock units suggest an expectation of continued employment and potentially the achievement of performance goals.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates the ongoing compensation and equity ownership structure for Astrana Health's leadership.

Comparison to Industry Standards

• Stock-based compensation is a common practice in the healthcare industry to align executive incentives with shareholder value.
• Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also utilize restricted stock units and stock options as part of their executive compensation packages.
• The vesting schedules and performance-based conditions are typical features designed to retain talent and drive performance.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding executive compensation and ownership.
• The vesting schedules incentivize the executive to remain with the company, potentially benefiting employees and customers through continued leadership.

Key Dates